Neurology Minute podcast

The Amyloid Hypothesis for Alzheimer's disease and Aducanumab

0:00
1:57
Recuar 15 segundos
Avançar 15 segundos

Dr. Erik Musiek discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer's disease.

Mais episódios de "Neurology Minute"